Ultrasound contrast developer Acusphere said it intends to raise $20 million in a "registered direct" stock offering to institutional investors.
Acusphere has agreed to sell 7.7 million shares of stock and warrants for a purchase price per unit of $2.60. The company estimates that net proceeds from the offering will be approximately $18.65 million, after deducting placement agent fees and estimated offering expenses.
By AuntMinnie.com staff writers
June 13, 2007
Related Reading
Acusphere reports results from Imagify phase III trials, May 4, 2007
Acusphere taps Bucceri for regulatory post, February 5, 2007
Acusphere to raise $23 million, December 7, 2006
Acusphere names Jaffe as VP, September 21, 2006
Acusphere licenses US contrast technology rights from GE, June 6, 2006
Copyright © 2007 AuntMinnie.com
